PODCAST · health
Addressing Neurodevelopment, Qualify of Life and Emerging Therapies in Dravet Syndrome Patients
by Annenberg Center for Health Sciences
The combined developmental and epileptic encephalopathy of Dravet syndrome provides significant diagnostic and treatment challenges. This activity focuses on key characteristics and clinical presentations of Dravet syndrome with the aim of early identification of persons with the syndrome, timely initiation and appropriate use of approved medications, and the need for a multidisciplinary care plan, particularly as individuals transition into adulthood. Dr. Wirrell also provides an overview of investigational disease-modifying therapies.
-
4
Disease-Modifying Therapies
Antisense oligonucleotide– zorevunersenHistamine antagonist– clemizole hydrochlorideSerotonin agonist– bexicaserinGene therapy– ETX101
-
3
Optimizing Standards of Care
Seizure management–cannabidiol, fenfluramine, stiripentol; ketogenic diet Multidisciplinary careDravet Syndrome Foundation Transition GuideSeizure action plan
-
2
Improving Diagnosis
Key features and triggersImagingDS mimicsGenetic testing
-
1
Developmental and Epileptic Encephalopathy
Description and courseComorbiditiesSCN1A gene mutationDisease burden
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
The combined developmental and epileptic encephalopathy of Dravet syndrome provides significant diagnostic and treatment challenges. This activity focuses on key characteristics and clinical presentations of Dravet syndrome with the aim of early identification of persons with the syndrome, timely initiation and appropriate use of approved medications, and the need for a multidisciplinary care plan, particularly as individuals transition into adulthood. Dr. Wirrell also provides an overview of investigational disease-modifying therapies.
HOSTED BY
Annenberg Center for Health Sciences
Loading similar podcasts...
URL copied to clipboard!